IGMS Similar Chart Price Prediction
The price of IGMS is predicted to go up -1.12%, based on the high correlation periods with ESRT. The similarity of these two price pattern on the periods is 94.36%.
IGMS
ESRT
Down: -1.12%Similarity: 94.36%
IGMS Revenue Forecast
IGMS EPS Forecast
IGMS FAQs
What is IGMS revenue forecast for next quarter？
IGMS Analyst's Forecast
Eric Joseph
JP Morgan
Sell → Hold
2025-01-13
Price Target
n/a
Downside
0%
JPMorgan upgraded IGM Biosciences to Neutral from Underweight without a price target. The firm says that with the company announcing discontinuation of imvotamab development alongside a pause of its clinical stage IgM assets, it sees its Underweight thesis "now borne out." Given the uncertain path forward for IGM, JPMorgan no longer ascribes pipeline value in its updated model for shares.
Roger Song
Jefferies
Strong Buy → Hold
2025-01-10
Price Target
$48 → $2
Downside
-4.31%
Asthika Goonewardene
Truist Securities
Hold
2025-01-10
Price Target
$12 → $2
Downside
-4.31%
